Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 A new function of the activated third component of complement: binding to C5, an essential step for C5 activation.

× No keyword cloud information.

12 in total

1. Formation and composition of the C3 activating enzyme complex of the properdin system. Sequential assembly of its components on solid-phase trypsin-agarose.

Authors: W Vogt; G Schmidt; L Dieminger; R Lynen
Journal: Z Immunitatsforsch Exp Klin Immunol Date: 1975-07

2. The properdin system and immunity. IX. Studies on the purification of human properdin.

Authors: E W TODD; L PILLEMER; I H LEPOW
Journal: J Immunol Date: 1959-10 Impact factor: 5.422

3. A new activity of complement component C3: cell-bound C3b potentiates lysis of erythrocytes by C5b,6 and terminal components.

Authors: C H Hammer; A S Abramovitz; M M Mayer
Journal: J Immunol Date: 1976-09 Impact factor: 5.422

4. Complement activation by the properdin system: formation of a stoichiometric. C3 cleaving complex of properdin factor B with C36.

Authors: W Vogt; W Dames; G Schmidt; L Dieminger
Journal: Immunochemistry Date: 1977-03

5. A new preparative method for isolation of human C3 with affinity chromatography.

Authors: J L Molenaar; M Müller; K W Pondman
Journal: J Immunol Date: 1973-06 Impact factor: 5.422

6. Changes in antigenic properties of human C3 upon activation and conversion by trypsin.

Authors: J L Molenaar; M A Müller; C P Engelfriet; K W Pondman
Journal: J Immunol Date: 1974-04 Impact factor: 5.422

7. Purification and some properties of a heat labile serum factor (UP); identity with glycine-rich beta-glycoprotein and properdin factor B.

Authors: R Lynen; V Brade; A Wolf; W Vogt
Journal: Hoppe Seylers Z Physiol Chem Date: 1973-01

8. Purification and some properties of factor D of the human properdin system.

Authors: L Dieminger; W Vogt; R Lynen
Journal: Z Immunitatsforsch Immunobiol Date: 1976-11

9. Alternative pathway of complement: recruitment of precursor properdin by the labile C3/C5 convertase and the potentiation of the pathway.

Authors: R G Medicus; O Götze; H J Müller-Eberhard
Journal: J Exp Med Date: 1976-10-01 Impact factor: 14.307

10. Complement as a mediator of inflammation. II. Biological properties of anaphylatoxin prepared with purified components of human complement.

Authors: W Dias Da Silva; I H Lepow
Journal: J Exp Med Date: 1967-05-01 Impact factor: 14.307

26 in total

1. Mutants of complement component C3 cleaved by the C4-specific C1-s protease.

Authors: P Mathias; C J Carrillo; N E Zepf; N R Cooper; R T Ogata
Journal: Proc Natl Acad Sci U S A Date: 1992-09-01 Impact factor: 11.205

2. Regulation of C5 convertase activity by properdin, factors B and H.

Authors: J M Weiler
Journal: Immunol Res Date: 1989 Impact factor: 2.829

3. Incomplete inhibition by eculizumab: mechanistic evidence for residual C5 activity during strong complement activation.

Authors: Markus J Harder; Nadine Kuhn; Hubert Schrezenmeier; Britta Höchsmann; Inge von Zabern; Christof Weinstock; Thomas Simmet; Daniel Ricklin; John D Lambris; Arne Skerra; Markus Anliker; Christoph Q Schmidt
Journal: Blood Date: 2016-12-27 Impact factor: 22.113

4. Structural basis for therapeutic inhibition of complement C5.

Authors: Matthijs M Jore; Steven Johnson; Devon Sheppard; Natalie M Barber; Yang I Li; Miles A Nunn; Hans Elmlund; Susan M Lea
Journal: Nat Struct Mol Biol Date: 2016-03-28 Impact factor: 15.369

5. C3 nephritic factor (C3NeF): dissociation of cell-bound and fluid phase stabilization of alternative pathway C3 convertase.

Authors: Y C Ng; D K Peters
Journal: Clin Exp Immunol Date: 1986-08 Impact factor: 4.330

Review 6. The properdin pathway: an "alternative activation pathway" or a "critical amplification loop" for C3 and C5 activation?

Authors: Richard A Harrison
Journal: Semin Immunopathol Date: 2017-11-22 Impact factor: 9.623

Review 7. The alternative pathway of complement.

Authors: M K Pangburn; H J Müller-Eberhard
Journal: Springer Semin Immunopathol Date: 1984

Review 8. The membrane attack complex.

Authors: H J Müller-Eberhard
Journal: Springer Semin Immunopathol Date: 1984

9. Effect on the human complement system of the major non-steroidal anti-inflammatory drugs: aspirin, indomethacin, phenylbutazone, oxyphenbutazone and sulindac.

Authors: J O Minta; M B Urowitz; H A Smythe; D E Isenman
Journal: Clin Exp Immunol Date: 1983-09 Impact factor: 4.330

10. The conversion of human complement component C5 into fragment C5b by the alternative-pathway C5 convertase.

Authors: R G DiScipio
Journal: Biochem J Date: 1981-12-01 Impact factor: 3.857